There’s a familiar rhythm to November in Canada: the first real cold snaps, the early darkness, and that gradual drumbeat toward Black Friday, Cyber Monday, and Boxing Day. It's the season where most of us try to be generous without tipping our personal budgets into chaos. So PayPal choosing now to launch PayPal Pay in 4 in Canada feels like a fairly intuitive move, like adding … [Read more...] about PayPal Pay in 4 Arrives in Canada for the Holiday Rush
Briefing
NuScale Power: The SMR Bet Moves From Concept to Commercial Deployment
The latest quarter for NuScale Power reads less like a standard earnings update and more like the moment a long-promised technology finally steps onto the commercial stage. For years, NuScale has held a unique position in the nuclear landscape: the first and only small modular reactor (SMR) design to secure approval from the U.S. Nuclear Regulatory Commission. That regulatory … [Read more...] about NuScale Power: The SMR Bet Moves From Concept to Commercial Deployment
The Waiting Game at the Bank of England
There’s a kind of quiet tension in the air whenever the Bank of England edges near a rate decision. You can almost picture a long wooden table, stacks of briefing papers, the light outside that flat grey London window, and a handful of people whose raised eyebrows can send markets into a sprint. If the Bank does hold rates this Thursday, as many expect, it won’t be because the … [Read more...] about The Waiting Game at the Bank of England
Maersk Q3 2025: The Quiet Rebuild of a Global Trade Powerhouse
There’s a subtle shift running through Maersk’s latest results, something steadier than the volatility of the last few years. The headline numbers show a company adjusting to a post-boom environment: revenue down year-on-year because freight rates have normalized, profitability lower than the pandemic’s distorted peaks. Yet the tone of the quarter feels more confident than … [Read more...] about Maersk Q3 2025: The Quiet Rebuild of a Global Trade Powerhouse
Tempus AI: Scaling Into an Inflection Point
Tempus delivered the kind of quarter that forces you to reconsider where the company sits in its maturity curve. Revenue in Q3 2025 grew 84.7% year-over-year to $334.2 million, driven primarily by continued strength in genomic testing and accelerating demand across both oncology and hereditary diagnostics. Importantly, the company did not just grow the top line; it expanded … [Read more...] about Tempus AI: Scaling Into an Inflection Point